Indications, methodology, and classification of results of tilt-table testing

American Journal of Cardiology

Volumn 84, Issue 8 SUPPL. 1, 1999, Pages 10-19

  Sutton, Richard ^a   Bloomfield, Daniel M ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; MIDODRINE;

AUTONOMIC DYSFUNCTION; COLLAPSE; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SYNCOPE; TILT TABLE TEST;

EID: 0032704894     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(99)00692-x     Document Type: Review

References (25)

1. Kenny R.A., Bayliss J., Ingram A., Sutton R. Head-up tilt a useful test for investigating unexplained syncope . Lancet. 1:1986;1352-1355.
2. Benditt D.G., Ferguson D.W., Grubb B.P., Kapoor W.N., Kugler J., Lerman B.B., Maloney J.D., Raviele A., Ross B., Sutton R., Wolk M.J., Wood D.L. Tilt table testing for assessing syncope American College of Cardiology . J Am Coll Cardiol. 28:1996;263-275.
3. Fitzpatrick A., Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet. i:1989;658-660.
4. Abi-Samra F., Maloney J.D., Fouad-Tarazi F.M., Castle L.W. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. PACE Pacing Clin Electrophysiol. 11:1988;1202-1214.
5. Benditt D.G., Remole S., Bailin S., Dunnigan A., Asso A., Milstein S. Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope rationale and proposed protocols . PACE Pacing Clin Electrophysiol. 14:1991;1528-1537.
6. Fitzpatrick A., Williams T., Ahmed R. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Pacing Electrophysiol. 2:1992;121-128.
7. Klingenheben T., Kalusche D., Li Y.G., Schopperl M., Hohnloser S.H. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope correlation with successful therapy with beta-receptor antagonists . J Cardiovasc Electrophysiol. 7:1996;802-808.
8. Sutton R., Petersen M., Brignole M., Raviele A., Menozzi C., Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Pacing Electrophysiol. 3:1992;180-183.
9. Almquist A., Goldenberg I.F., Milstein S., Chen M.Y., Chen X., Hansen R., Gornick C.C., Benditt D.G. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 320:1989;346-351.
10. Raviele A., Menozzi C., Brignole M., Gasparini G., Alboni P., Musso G., Lolli G., Oddone D., Dinelli M., Mureddu R. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol. 76:1995;267-272.
11. Petersen M.E., Williams T.R., Sutton R. A comparison of non-invasive continuous finger blood pressure measurement (Finapres) with intra-arterial pressure during prolonged head-up tilt. Eur Heart J. 16:1995;1641-1654.
12. Natale A., Akhtar M., Jazayeri M.R., Dhala A., Blanck Z., Deshpande S., Krebs A., Sra J.S. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation. 92:1995;54-58.
13. Fitzpatrick A.P., Theodorakis G., Vardas P., Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 17:1991;125-130.
14. Bloomfield D., Maurer M., Bigger J.T.J. Effects of age on outcome of tilt-table testing. Am J Cardiol. 83:1999;1055-1058.
15. Petersen ME, Sutton R. The normal response to prolonged passive head-up tilt testing. Heart. In press.
16. Kurbaan A.S., Franzén A.C., Bowker T.J., Williams T.R., Kaddoura S., Petersen M.E., Sutton R. Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin. Am J Cardiol. 84:1999;665-670.
17. Grubb B.P., Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance an overview of classification, clinical evaluation, and management . PACE Pacing Clin Electrophysiol. 22:1999;798-810.
18. Benditt D.G. Neurally mediated syncopal syndromes pathophysiological concepts and clinical evaluation . PACE Pacing Clin Electrophysiol. 20:1997;572-584.
19. Sutton R., Petersen M.E. The economics of treating vasovagal syncope. PACE Pacing Clin Electrophysiol. 20:1997;849-850.
20. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, Suarez GA, Rummans TA. Postural tachycardia syndrome (POTS). Neurology 1995;45(4, suppl 5):S19-S25.
21. Grubb B.P., Kosinski D.J., Boehm K., Kip K. The postural orthostatic tachycardia syndrome a neurocardiogenic variant identified during head-up tilt table testing . PACE Pacing Clin Electrophysiol. 20:1997;2205-2212.
22. Bloomfield D., Sheldon R., Grubb B.P., Calkins H., Sutton R. Putting it together a new treatment algorithm for vasovagal syncope and related disorders . Am J Cardiol. 84:1999;33Q-39Q.
23. Raviele A., Brignole M., Sutton R., Alboni P., Giani P., Menozzi C., Moya A. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope a double-blind, randomized, placebo-controlled trial . Circulation. 99:1999;1452-1457.
24. Connolly S.J., Sheldon R., Roberts R.S., Gent M. The North American Vasovagal Pacemaker Study (VPS) a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope . J Am Coll Cardiol. 33:1999;16-20.
25. Petersen M.E., Chamberlain-Webber R., Fitzpatrick A.P., Sutton R. Reproducibility of the Westminster tilt protocol. (Abstr.) J Am Coll Cardiol. 19:1992;340.